Table 1. Clinical characteristics of analyzed CLL patients.
Characteristics | Median (range) | Number of patients/percentage |
---|---|---|
Sex | ||
Female | 30 | |
Male | 36 | |
Age | 63 (38–85) | |
Rai stadium | ||
0 | 31% | |
I | 17% | |
II | 30% | |
III | 8% | |
IV | 14% | |
CD38 expression | ||
Negative | 56% | |
Positive | 44% | |
ZAP-70 expression | ||
Negative | 68% | |
Positive | 32% | |
Cytogenetics | ||
Low-risk | 60% | |
High-risk | 40% | |
First-line therapy | ||
Fludarabine-based regimens | 30 | |
Chlorambucil+/−Prednisone | 7 | |
Bendamustine | 1 |